Sep 4, 2025
Post-marketing surveillance (PMS) is a critical component of pharmacovigilance, ensuring ongoing drug safety after products reach the market. However, traditional PMS approaches face rising complexity due to exploding data volumes, underreporting, and manual workflows that hinder timely decision-making. This white paper explores how artificial intelligence (AI) - including natural language processing (NLP),large language models (LLMs), knowledge graphs, and retrieval-augmented generation (RAG) - is transforming PMS. It introduces PharmaVigil, Zensar’s AI-powered platform that supports the entire pharmacovigilance lifecycle: signal detection, literature intelligence, case processing, and compliance.
Read the white paper to know more!